Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Travis Hollmann

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Science (New York, N.Y.)|September 13, 2021
Developmental chromatin programs determine oncogenic competence in melanomaArianna Baggiolini, Scott J Callahan, Emily Montal, et al.
Nature Biotechnology|November 19, 2021
Whole-cell segmentation of tissue images with human-level performance using large-scale data annotation and deep learningNoah F Greenwald, Geneva Miller, Erick Moen, et al.
Nature Medicine|April 23, 2024
Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analysesClaire F Friedman, Beryl L Manning-Geist, Qin Zhou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 17, 2018
Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation SequencingHira Rizvi, Francisco Sanchez-Vega, Konnor La, et al.
Blood|October 15, 2021
A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomasAlison J Moskowitz, Paola Ghione, Eric Jacobsen, et al.
Cancer Cell|July 25, 2020
Emergence of a High-Plasticity Cell State during Lung Cancer EvolutionNemanja Despot Marjanovic, Matan Hofree, Jason E Chan, et al.
Nature Genetics|June 3, 2020
Unraveling tumor-immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapyAlejandro Jiménez-Sánchez, Paulina Cybulska, Katherine LaVigne Mager, et al.
Nature Communications|September 1, 2018
Loss-of-function mutations in ATP6AP1 and ATP6AP2 in granular cell tumorsFresia Pareja, Alissa H Brandes, Thais Basili, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Science (New York, N.Y.)|September 13, 2021
Developmental chromatin programs determine oncogenic competence in melanomaArianna Baggiolini, Scott J Callahan, Emily Montal, et al.
Nature Biotechnology|November 19, 2021
Whole-cell segmentation of tissue images with human-level performance using large-scale data annotation and deep learningNoah F Greenwald, Geneva Miller, Erick Moen, et al.
Nature Medicine|April 23, 2024
Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analysesClaire F Friedman, Beryl L Manning-Geist, Qin Zhou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 17, 2018
Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation SequencingHira Rizvi, Francisco Sanchez-Vega, Konnor La, et al.
Blood|October 15, 2021
A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomasAlison J Moskowitz, Paola Ghione, Eric Jacobsen, et al.
Cancer Cell|July 25, 2020
Emergence of a High-Plasticity Cell State during Lung Cancer EvolutionNemanja Despot Marjanovic, Matan Hofree, Jason E Chan, et al.
Nature Genetics|June 3, 2020
Unraveling tumor-immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapyAlejandro Jiménez-Sánchez, Paulina Cybulska, Katherine LaVigne Mager, et al.
Nature Communications|September 1, 2018
Loss-of-function mutations in ATP6AP1 and ATP6AP2 in granular cell tumorsFresia Pareja, Alissa H Brandes, Thais Basili, et al.
Pageof 2